Trial intelligence / Profile preview

Target Weaning Oxygen to Determine Duration of Caffeine for Apnea of Prematurity

NCT04868565Phase 4Completed

Sponsor
Children's Hospital of Chongqing Medical University
Start
May 2021
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of caffeine in apnea of prematurity (AOP), sponsored by Children's Hospital of Chongqing Medical University. Started May 2021; status: completed.

02

Drugs

caffeine
03

Conditions

apnea of prematurity (AOP)

Beyond the preview

Go deeper on NCT04868565.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04868565.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call